Print Page  |  Close Window

SEC Filings

SC 13G/A
TPG GROUP HOLDINGS (SBS) ADVISORS, INC. filed this Form SC 13G/A on 02/13/2017
Entire Document
 

 

Item 1(a). Name of Issuer:



                 Collegium Pharmaceutical, Inc. (the “Issuer”)

Item 1(b). Address of Issuer’s Principal Executive Offices:


780 Dedham Street, Suite 800

Canton, Massachusetts 02021

Item 2 (a).

Name of Person Filing:

This Schedule 13G is being filed jointly by TPG Group Holdings (SBS) Advisors, Inc., a Delaware corporation (“Group Advisors”), David Bonderman and James G. Coulter (each, a “Reporting Person” and, together, the “Reporting Persons”), pursuant to an Agreement of Joint Filing incorporated by reference herein in accordance with Rule 13d-1(k)(1) under the Act.

 

Group Advisors is sole member of TPG Group Holdings (SBS) Advisors, LLC, a Delaware limited liability company, which is the general partner of TPG Group Holdings (SBS), L.P., a Delaware limited partnership, which is the sole member of TPG Holdings I-A, LLC, a Delaware limited liability company, which is the general partner of TPG Holdings I, L.P., a Delaware limited partnership, which is the sole member of TPG Biotechnology GenPar IV Advisors, LLC, a Delaware limited liability company, which is the general partner of TPG Biotechnology GenPar IV, L.P., a Delaware limited partnership, which is the general partner of TPG Biotechnology Partners IV, L.P., a Delaware limited partnership (“TPG Biotech IV”), which directly holds 1,389,863 shares of Common Stock of the Issuer (the “Shares”) reported herein. Because of Group Advisors’ relationship to TPG Biotech IV, Group Advisors may be deemed to beneficially own the Shares directly held by TPG Biotech IV.

 

David Bonderman and James G. Coulter are sole shareholders of Group Advisors, and may therefore be deemed to beneficially own the Shares held by TPG Biotech IV. Messrs. Bonderman and Coulter disclaim beneficial ownership of the Shares except to the extent of their pecuniary interest therein.

 

Item 2 (b).

Address of Principal Business Office or, if none, Residence:

The principal business address of each of the Reporting Persons is as follows: 

c/o TPG Global, LLC

301 Commerce Street, Suite 3300

Fort Worth, Texas 76102

Item 2 (c). Citizenship:
See responses to Item 4 on each cover page.
Item 2 (d). Title of Class of Securities:
Common Stock, $0.001 par value (“Common Stock”)
Item 2 (e). CUSIP Number:
19459J104
  Page 5 of 9